CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...